These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 6356284

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined amphotericin B and rifampin treatment of experimental Candida albicans keratitis.
    Stern GA, Okumoto M, Smolin G.
    Arch Ophthalmol; 1979 Apr; 97(4):721-2. PubMed ID: 426691
    [Abstract] [Full Text] [Related]

  • 5. In vivo tests for antimycotic drugs.
    Gargani G, Pini G.
    Chemioterapia; 1985 Oct; 4(5):406-12. PubMed ID: 3935334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans.
    Moneib NA.
    J Chemother; 1995 Dec; 7(6):525-9. PubMed ID: 8667037
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.
    Titsworth E, Grunberg E.
    Antimicrob Agents Chemother; 1973 Sep; 4(3):306-8. PubMed ID: 4586144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination.
    Sugar AM.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1669-71. PubMed ID: 1929339
    [Abstract] [Full Text] [Related]

  • 14. Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis.
    Mencacci A, Cenci E, Bacci A, Bistoni F, Romani L.
    J Infect Dis; 2000 Feb; 181(2):686-94. PubMed ID: 10669356
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
    Clemons KV, Stevens DA.
    J Antimicrob Chemother; 2001 Feb; 47(2):183-6. PubMed ID: 11157903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy.
    Sugar AM, Goldani LZ, Picard M.
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2128-30. PubMed ID: 1759836
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism.
    Han Y.
    Biol Pharm Bull; 2007 Sep; 30(9):1693-6. PubMed ID: 17827722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.